source
- Top pharma firms line up for Summit Therapeutics' ivonescimab after strong China Phase 3 dataSeveral major biopharma companies, including AstraZeneca, Pfizer and Revolution Medicines, are expressing strong interest in Summit Therapeutics' Akeso-partnered bispecific antibody ivonescimab. Th…
- Saudi Arabia pushes ahead with biotech hub despite regional instabilitySaudi Arabia is constructing a regulatory framework, partnership networks and intellectual property structures to nurture a biotech ecosystem, even as regional political tensions persist. Experts…